ATR-IN-20 is a potent ATR (ATM/ATR) inhibitor with an IC50 of 3 nM; it also exhibits inhibitory activity against mTOR (IC50 = 18 nM) and demonstrates good selectivity over PI3Kα (100 nM), ATM (100 nM), and DNA-PK (662 nM); it possesses favorable pharmacokinetic properties (F = 30%) and shows anticancer activity.